Evidence

Displaying 21 - 30 of 123, sorted by most recent

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings

Christopher Jones, Hanna Umanskiy Ortiz

December 3, 2020

Dr. Christopher Jones, U.S. Public Health Service and Centers for Disease Control and Prevention (CDC), reviews current options (to include methadone, buprenorphine and naltrexone) in Medication-Assisted Treatment (MAT) for those with an opioid use disorder.

Treatment of Incarcerated Individuals with Opioid Use Disorders

Cathy Thompson

December 3, 2020

Dr.

Summary

Irene M. Keeley

December 3, 2020

In concluding remarks, Judge Irene Keeley (N.D. W.

Amendments to the Federal Rules of Practice and Procedure 2020—Transmittal to Congress

April 27, 2020

This package of materials was transmitted to Congress on April 27, 2020, concerning amendments to the Federal Rules of Practice and Procedure to become effective on December 1, 2020.

Amendments to the Federal Rules of Practice and Procedure are as follows:

Amendments to the Federal Rules of Practice and Procedure: Evidence 2019—The Residual Hearsay Exception

January 7, 2020

In 2019, the residual hearsay exception, Federal Rules of Evidence 807, was amended to fix a number of problems that courts had encountered applying the rule.

Amendments to the Federal Rules of Practice and Procedure 2020—Transmittal to the Supreme Court

October 23, 2019

This package of materials was transmitted to the U.S. Supreme Court on October 23, 2019, concerning amendments to the Federal Rules of Practice and Procedure to become effective on December 1, 2020.

Amendments to the Federal Rules of Practice and Procedure 2019—Transmittal to Congress

April 25, 2019

This package of materials was transmitted to Congress on April 25, 2019, concerning amendments to the Federal Rules of Practice and Procedure to become effective on December 1, 2019.

Amendments to the Federal Rules of Practice and Procedure are as follows:

Memory, Lie and Recognition Detection

Craig Stark

February 7, 2019

In this module, Dr. Craig Stark from the University of California, Irvine, discusses how memory is encoded in the brain, how memories can be manipulated, and why these topics are relevant to the courts. He addresses the following questions:

Summary

Jed S. Rakoff

February 7, 2019

Judge Jed S. Rakoff provides concluding remarks.

Pain Detection

David Thomas

February 7, 2019

In this module, Dr. David Thomas, founding member of the National Institutes of Health (NIH) Pain Consortium, provides an overview of the neuroscience of pain and seeks to answer the following questions:

Federal Judicial Center

You are here

Evidence

Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings

Treatment of Incarcerated Individuals with Opioid Use Disorders

Summary

Amendments to the Federal Rules of Practice and Procedure 2020—Transmittal to Congress

Amendments to the Federal Rules of Practice and Procedure: Evidence 2019—The Residual Hearsay Exception

Amendments to the Federal Rules of Practice and Procedure 2020—Transmittal to the Supreme Court

Amendments to the Federal Rules of Practice and Procedure 2019—Transmittal to Congress

Memory, Lie and Recognition Detection

Summary

Pain Detection

Pages